GlassScriptPhysician profile
Kristen Maritato
NPI 1225466899
$7,650.03
in general payments reported to CMS, 2019-2025
39 companies · $2,510 in 2025
The $2,510 reported for 2025 was more than what 94% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,319 · 2022: $670 · 2023: $1,389 · 2024: $1,762 · 2025: $2,510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,661.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,660.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,449.35 | 2021-2025 | |
| Novo Nordisk INC | $1,031.80 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $927.92 | 2021-2025 | Xifaxan |
| Astrazeneca Pharmaceuticals LP | $598.83 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Glaxosmithkline, LLC. | $578.34 | 2021-2025 | Trelegy Ellipta, Arexvy |
| Pfizer INC. | $539.97 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $415.48 | 2022-2025 | Rexulti |
| Lilly USA, LLC | $316.71 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Phathom Pharmaceuticals, INC. | $257.44 | 2024-2025 | Voquezna |
| Sumitomo Pharma America, INC. | $146.18 | 2023-2025 | Gemtesa |
| Amgen INC. | $137.36 | 2021-2025 | Otezla, Repatha, Otezla |
| Exact Sciences Corporation | $134.20 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Lundbeck LLC | $130.70 | 2024-2025 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $122.25 | 2021-2025 | Eliquis, Camzyos |
| Axsome Therapeutics, INC. | $117.97 | 2023-2025 | Auvelity, Sunosi |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristen Maritato listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.